Go Back
Century Therapeutics, Inc. reports $31.3 million Q1 loss
By USInMinutes - May 11, 2023, 03:06 PM ET
Last Updated - Aug 12, 2024, 08:22 AM EDT
The company generated $1.70 million in quarterly revenue
Century Therapeutics, Inc. [IPSC] has reported fiscal Q1 loss of $31.30 million.
Sponsored
On a per-share basis, the DE based company said its diluted earnings are $0.53.
The Biological Products, Except Diagnostic Substances firm posted revenue of $1.70 million in this period.
By continuing to use this site, you agree to our terms and conditions
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Read More from EarningsNews
Read More from USinMinutes
Popular News
Latest News